Provided by Tiger Trade Technology Pte. Ltd.

Phathom Pharmaceuticals

6.78
-0.0300-0.44%
Volume:11.36K
Turnover:76.95K
Market Cap:548.51M
PE:-5.36
High:6.79
Open:6.79
Low:6.68
Close:6.81
52wk High:18.31
52wk Low:6.52
Shares:80.90M
Float Shares:63.93M
Volume Ratio:0.37
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2659
EPS(LYR):-3.0342
ROE:-3489.00%
ROA:-8.80%
PB:-1.59
PE(LYR):-2.23

Loading ...

Apr 04, 2023

Major Issues Report

8-K - Current report
Mar 09, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Major Issues Report

8-K - Current report
Feb 02, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Jan 03, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 01, 2022

Major Issues Report

8-K - Current report
Oct 24, 2022

Major Issues Report

8-K - Current report
Sep 29, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Major Issues Report

8-K - Current report
Sep 26, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership